Inventor · disambiguated record
Kevin R. Webster
Also filed as: WEBSTER KEVIN R · WEBSTER KEVIN RICHARD
12 granted patents·7 pending applications·370 citations·filing 1994–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0194US6720347B2Carbon substituted aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 13, 2004·32 cites·2 claims
- 0289US6262096B1Aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 17, 2001·81 cites·1 claims
- 0388US6107305AUse of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Aug 22, 2000·88 cites·26 claims
- 0488US6040321AAminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Mar 21, 2000·85 cites·45 claims
- 0583US6407124B1Carbon substituted aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 18, 2002·26 cites·9 claims
- 0680US10780119B2Methods and compositions for cellular immunotherapyEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·1 cites·10 claims
- 0778US10702526B2Inhibitors of immune checkpoint modulators and related methodsEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jul 7, 2020·2 cites·23 claims
- 0875US5625031APeptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoproteinBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Apr 29, 1997·44 cites·5 claims
- 0974US6534531B2Methods for preventing and treating alopecia induced by chemotherapy or radiotherapyBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 18, 2003·5 cites·43 claims
- 1074US6521759B2Aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 18, 2003·6 cites·1 claims
- 1173US2023381232A1Methods and compositions for cellular immunotherapyEFFECTOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1269US11564947B2Methods and compositions for cellular immunotherapyEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Jan 31, 2023·0 cites·20 claims
- 1357US2021046074A1Inhibitors of immune checkpoint modulators and related methodsEFFECTOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1453US2025093362A1High-throughput engineering of molecular gluesFRONTIER MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1553US2007105114A1Biomarkers of cyclin-dependent kinase modulationLI MARTHA·Filed 2004·Application pending·0 cites
- 1651US2022378821A1Methods of treating braf-mutated cancer cellsEFFECTOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1751US2021299111A1Eif4a inhibitor combinationsEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1845US11576933B2Compositions and methods for an improved antitumor immune responseEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Feb 14, 2023·0 cites·16 claims
- 1942US2003114504A1Compositions and methods for the treatment of cancerFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin R. Webster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →